Indian regulators are accused of laxity in not banning drugs.
Mudur
Ganapati
G
D018501:Antirheumatic Agents / Q000009:adverse effects*; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D006801:Humans; D007194:India; D007783:Lactones / Q000009:adverse effects*; D013450:Sulfones
D018501:Antirheumatic Agents; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib